PMDA drug package insert
弗化ナトリウム液「ネオ」
PMDA Prescription drug · ネオ製薬工業株式会社 · package insert Apr 6, 2026
Key facts
| Brand names | 弗化ナトリウム液「ネオ」 |
|---|---|
| Nonproprietary names | フッ化ナトリウム |
| Companies | 製造販売元／ネオ製薬工業株式会社, 発売元／株式会社ナルコーム |
| Product type | Prescription drug |
| Therapeutic category | 齲蝕予防剤 |
| Therapeutic category codes | 87279 |
| YJ codes | 2790822Q1031 |
| Approval numbers | 14200AMZ00018000 |
| Package insert edition | 第2版 |
| Package insert date | Apr 6, 2026 |
| PMDA document key | 610003_2790822Q1031_1 |
| PMDA company code | 610003 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: